Panel · Use case · Public Affairs

Payer Stakeholder Rehearsal.

LiveStakeholder Rehearsal

Rehearse the stakeholder conversation before the live meeting: a payer, a clinician, a patient advocate and an HTA official, simulated by specialists.

MeetingA stakeholder conversation on a client position

ConstituenciesPayer, clinician, patient advocate, HTA official

ReaderAccess and public affairs leads

Not askedA prediction of the live room

DepthStandard, four seats

Payer Stakeholder Rehearsal is a ready-made use case for Public Affairs. It ships under the Stakeholder Rehearsal template.

For public affairs leads preparing a live meeting. You get each simulated constituency's position, where they conflict, the objections with proposed responses and what each would need to move. The constituencies are simulated, not consulted. Claims are cited or marked as gaps.

Add it to your library to reuse from New → From template. Edit the saved copy in your library on the service form.

The decision

How will a payer, a treating clinician, a patient advocate and a ministry or HTA official each receive the client’s position at the live meeting?

Who is simulated

Each constituency is briefed on what its real counterparts have said publicly: assessment methods, guidelines and published decisions. A seat may stay unpersuaded.

Constituency simulated	What it is asked	What it works from
Payer	Whether the evidence and price justify coverage, and what it would ask for in return.^{1Gemeinsamer Bundesausschuss (Federal Joint Committee). Benefit assessment of medicinal products. English page.}	Published payer policies and assessment methods.
Treating clinician	Whether the position fits clinical practice and what it would change for patients.	Guidelines and clinical evidence.
Patient advocate	Whether the position serves access and quality of life, and what is missing from the patient voice.	Patient group statements and published submissions.
Ministry or HTA official	Whether the position fits the national assessment and budget.^{1Gemeinsamer Bundesausschuss (Federal Joint Committee). Benefit assessment of medicinal products. English page.,2European Commission. Regulation on health technology assessment (Regulation (EU) 2021/2282): joint clinical assessments.}	The assessment framework, including the G-BA’s and the EU joint assessment.

What the rehearsal does

Conflict is the finding. Payers and advocates will want different things from the same evidence. The report shows the pairs that pull against each other and what each would trade.

National assessments set the frame. The HTA seat answers within the assessment method of the market in question, and cites it.^{1Gemeinsamer Bundesausschuss (Federal Joint Committee). Benefit assessment of medicinal products. English page.,2European Commission. Regulation on health technology assessment (Regulation (EU) 2021/2282): joint clinical assessments.}

What the rehearsal cannot tell you. The report states plainly what a simulation cannot know: the people, their mood, and any new information they bring.

Recommended length

Standard

Four constituencies are in the room. Standard depth gives each a seat and ends with what a rehearsal cannot tell you, in about four pages.

You can pick another length on the form. The other two stay available.

Assumptions the rehearsal checks

The rehearsal states the assumptions it makes about each constituency, and says what each gap limits. Examples for this meeting:

Public statements represent the constituency’s actual position.
The HTA body will apply its published method to this product.
The advocate group will be consulted by the assessor.

Standards, guidance and sources

Frame

G-BA, benefit assessment of medicinal products.^{1Gemeinsamer Bundesausschuss (Federal Joint Committee). Benefit assessment of medicinal products. English page.}
European Commission, joint clinical assessments under the HTA Regulation.^{2European Commission. Regulation on health technology assessment (Regulation (EU) 2021/2282): joint clinical assessments.}

The decision practice behind the memo itself is on the template page.

What gets flagged

Any position attributed to a constituency without a public source, any objection no response was prepared for, and any constituency that agrees with the sponsor on every point.

What arrives

The question put, and who was simulated
The stakeholder map
Each constituency's position
Where they conflict
Objections and responses
What each would need to move, and the order to engage
What a rehearsal cannot tell you

What it will not do

The constituencies are simulated by AI specialists and are not the real people. The rehearsal prepares you for objections you can anticipate and does not predict the live room.

It does not write the briefing for the live meeting.

It is not research with real stakeholders. The constituencies are simulated by AI specialists from stated sources, and they are not the real people.

It does not predict what the live room will say. It prepares you for the objections you can anticipate.

It does not script a response to be repeated. The responses are for you to test and to adapt.

References

[1] Gemeinsamer Bundesausschuss (Federal Joint Committee). Benefit assessment of medicinal products. English page. Read on 9 October 2026.
[2] European Commission. Regulation on health technology assessment (Regulation (EU) 2021/2282): joint clinical assessments. Known from search results; check the current page.

Links checked 9 October 2026

These are the sources the template drew on. None of their authors or issuers has reviewed it.

About the Panel service

Each panelist answers in their own voice, then the discussion is drawn together. You get the question and who was in the room, every position in full, what they agreed on, where they split, and what follows. Disagreements are written down rather than smoothed into a consensus nobody actually holds, because the split is usually the part you needed.

To edit a saved template, open New → Panel → From template, or the library rail on the service form.